Cost and outcome of treatment of adults with acute myeloid leukemia at the National Cancer Institute-Egypt.

Abstract

BACKGROUND Despite important advances in the therapy of acute myeloid leukemia (AML), the majority of patients die of their disease, unless bone marrow transplantation (BMT) is done. Infection and hemorrhage are still the major causes of mortality in AML patients. Progress in therapy and supportive care has led to gradual improvement in the overall results… (More)

Topics

Cite this paper

@article{ElZawahry2007CostAO, title={Cost and outcome of treatment of adults with acute myeloid leukemia at the National Cancer Institute-Egypt.}, author={Heba M. El-Zawahry and Ahmed Abdelmabood Zeeneldin and Mohamed A. Abou - Samra and Mervat M. Mattar and Mosaad Mahmoud El-Gammal and Ayman Abd El-Samee and Tarek Darwish}, journal={Journal of the Egyptian National Cancer Institute}, year={2007}, volume={19 2}, pages={106-13} }